Dendreon
Immunotherapy for prostate cancer
- B2B
About Dendreon
A pioneer in immunotherapy, Dendreon develops innovative treatments for prostate cancer using a patient's own immune cells to fight the disease
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- Seal Beach, California, United States
- Founded
- 1992
- Revenue
- $31.6M – $249MTamtam estimate
- Website
- dendreon.com
- linkedin.com/company/dendreon
Dendreon at a glance
Dendreon is a B2B company in the Biotechnology Research industry, headquartered in Seal Beach, California, United States.
Dendreon was founded in 1992.
Dendreon has 251–1,000 employees.
Dendreon's revenue is $31.6M – $249M (Tamtam estimate).
Selling to companies like Dendreon?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies